documents: FDA-2026-P-1794-0005
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2026-P-1794-0005 | FDA | FDA-2026-P-1794 | Attachment 3 Proposed Package Insert Rivaroxaban ODT | Supporting & Related Material | Background Material | 2026-02-18T05:00:00Z | 2026 | 2 | 2026-02-19T01:52:40Z | 0 | 0 | 09000064b91b9bfe |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref